Results from high-throughput tests measuring biological activity can help chemical manufacturers decide which molecular structures may be worth researching and developing for the marketplace, according to a Dow Chemical Co. toxicologist.
Ed Carney, director of predictive toxicology at Dow, told an audience of more than 200 government, industry, nonprofit and academic scientists Sept. 29 about diverse factors spurring chemical manufacturers to use data from high-throughput tests. These drivers, he said, include:
- the desire to make sustainable chemicals;
- the speed at which data can be generated, combined with the desire to have more data so that information from one chemical can ...